Blencowe Resources: Aspiring to become one of the largest graphite producers in the world. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

IN BRIEF: Abcam Launches Offering Of ADSs To List On Nasdaq Market

Mon, 19th Oct 2020 20:23

Abcam PLC - Cambridge-based reagents and tools for life science research - Launches offering of 8.9 million American Depositary Shares to list on the Nasdaq Global Market. Each ADS offered represents one ordinary share of Abcam. The ADSs are being offered in a registered public offering in US.

Current stock price: 1,325.00 pence

Year-to-date change: down 2.0%

By Arvind Bhunjun; arvindbhunjun@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

Related Shares

More News
20 Jun 2023 11:18

RBC Capital Markets downgrades Abcam to 'sector perform'

(Sharecast News) - RBC Capital Markets downgraded Abcam on Tuesday to 'sector perform' from 'outperform' and cut the price target to $22 from $23 as i...

20 Jun 2023 08:22

Broker tips: Ocado, Abcam

(Sharecast News) - Online supermarket Ocado was under the cosh on Tuesday after JPMorgan Cazenove cut its price target on the shares to 400p from 450p...

11 Jun 2023 14:36

Sunday newspaper round-up: Bank of England, Sturgeon, Melrose

(Sharecast News) - Experts believe that the Bank of England will have to jack up its base rate from 4.5% at present to 5.5% by the end of 2023 in orde...

12 Dec 2022 09:14

Abcam delisting from AIM going ahead this week

(Sharecast News) - Life science research tool specialist Abcam updated the market on the cancellation of its shares on AIM on Monday, which it first a...

17 Oct 2022 09:40

TOP NEWS: AIM to lose largest listing as Abcam to trade only on Nasdaq

(Alliance News) - Abcam PLC on Monday proposed delisting from AIM in London and retaining a sole listing on Nasdaq in New York.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.